Obesity and the Polycystic Ovary Syndrome
Overview
Authors
Affiliations
Polycystic ovarian syndrome (PCOS) is extremely common among reproductive-aged women, but often goes undiagnosed. PCOS is associated with the metabolic syndrome and carries a greatly increased risk of impaired glucose tolerance and type 2 diabetes mellitus, and cardiovascular risks. Treatment of PCOS may provide relief of cosmetic problems and depression by improving patient self-esteem. In addition, because of its association with the metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease, its recognition and treatment can potentially be life saving. This article reviews the impact, pathophysiology, and associated risks of obesity and the metabolic syndrome in PCOS.
Han Y, Wu H, Sun S, Zhao R, Deng Y, Zeng S Nutrients. 2023; 15(9).
PMID: 37432488 PMC: 10180647. DOI: 10.3390/nu15092230.
Wang H, Cao H, Cao J, Zhang L Biomed Res Int. 2023; 2023:1508675.
PMID: 36814799 PMC: 9940946. DOI: 10.1155/2023/1508675.
Zeng X, Huang Y, Zhang M, Chen Y, Ye J, Han Y Endocr Connect. 2021; 11(1).
PMID: 34822342 PMC: 8789017. DOI: 10.1530/EC-21-0243.
Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q Int J Endocrinol Metab. 2014; 12(1):e12470.
PMID: 24696694 PMC: 3968989. DOI: 10.5812/ijem.12470.
Agarwal S, Behere R, Venkatasubramanian G, Rao N, Varambally S, Gangadhar B Prim Care Companion CNS Disord. 2012; 13(5).
PMID: 22295263 PMC: 3267504. DOI: 10.4088/PCC.11l01164.